Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Puerto Rico has been experiencing some interesting trends and developments in recent years.
Customer preferences: Puerto Rico has a highly urbanized population, with the majority of the population living in metropolitan areas. This has led to a higher demand for vaccines that can prevent diseases that are easily transmitted in densely populated areas. Additionally, the island has a large elderly population, which has also contributed to an increasing demand for vaccines.
Trends in the market: One of the notable trends in the Other Vaccines market in Puerto Rico is the increasing demand for travel vaccines. As Puerto Rico is a popular tourist destination, there has been a growing need for vaccines that can protect visitors from diseases that are not prevalent in their home countries. Another trend is the increasing use of technology to improve vaccine delivery and tracking. This includes the use of electronic medical records and mobile apps to help patients keep track of their vaccine schedules.
Local special circumstances: Puerto Rico has a unique status as a territory of the United States, which has both positive and negative effects on the healthcare system. On the one hand, Puerto Rico has access to federal healthcare programs, which has helped to improve access to vaccines for many residents. On the other hand, the island's healthcare system has been struggling in recent years due to financial difficulties, which has led to shortages of some vaccines.
Underlying macroeconomic factors: The Puerto Rican economy has been struggling in recent years, which has had an impact on the healthcare system. The island has a high poverty rate, which has made it difficult for some residents to access healthcare services. Additionally, the island has been hit by a series of natural disasters in recent years, which has further strained the healthcare system. Despite these challenges, the government and healthcare providers are working to improve access to vaccines and other healthcare services for all residents.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
